By Dale Gillham · 26 May 2009 · Locked
The recent swine flu outbreak has sent investors scrambling to buy into Biota, but is this a smart investment or a reckless gamble? Find out what experts are saying about the risks and rewards of investing in the Tamiflu vaccine.
The recent outbreak of swine flu has sent speculators scrambling to buy into Biota, the company responsible for the Tamiflu vaccine in the hope of making a quick dollar. But is this really smart investing or just plain gambling? On Friday 24 April Biota closed at $0.87 before rising 78.16 percent to a high of […]